{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T01:29:08Z","timestamp":1786325348843,"version":"build-2736575974"},"reference-count":224,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270262"],"award-info":[{"award-number":["82270262"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070408"],"award-info":[{"award-number":["82070408"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400520"],"award-info":[{"award-number":["82400520"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.intimp.2026.117116","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:39:43Z","timestamp":1784259583000},"page":"117116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Diabetic cardiomyopathy: Target immune cell from mechanism to treatment"],"prefix":"10.1016","volume":"186","author":[{"given":"Jingyi","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolu","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoning","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.intimp.2026.117116_bb0005","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117116_bb0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","article-title":"Role of diabetes in congestive heart failure: the Framingham study","volume":"34","author":"Kannel","year":"1974","journal-title":"Am. J. Cardiol."},{"issue":"25","key":"10.1016\/j.intimp.2026.117116_bb0015","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1161\/CIRCULATIONAHA.106.679597","article-title":"Diabetic cardiomyopathy revisited","volume":"115","author":"Boudina","year":"2007","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.intimp.2026.117116_bb0020","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","article-title":"Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways","volume":"142","author":"Huynh","year":"2014","journal-title":"Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.intimp.2026.117116_bb0025","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic mechanisms of diabetic heart disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.117116_bb0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","article-title":"Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease","volume":"61","author":"Jia","year":"2018","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.intimp.2026.117116_bb0035","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1111\/dom.16242","article-title":"Mechanisms of diabetic cardiomyopathy: focus on inflammation","volume":"27","author":"Bellemare","year":"2025","journal-title":"Diabetes Obes. Metab."},{"issue":"5","key":"10.1016\/j.intimp.2026.117116_bb0040","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ahj.2011.07.030","article-title":"Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysis","volume":"162","author":"Castagno","year":"2011","journal-title":"Am. Heart J."},{"issue":"5","key":"10.1016\/j.intimp.2026.117116_bb0045","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/dom.13629","article-title":"Heart failure and type 2 diabetes: from cardiovascular outcome trials, with hope","volume":"21","author":"Giugliano","year":"2019","journal-title":"Diabetes Obes. Metab."},{"issue":"12","key":"10.1016\/j.intimp.2026.117116_bb0050","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41577-018-0065-8","article-title":"Cardioimmunology: the immune system in cardiac homeostasis and disease","volume":"18","author":"Swirski","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117116_bb0055","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41577-021-00584-1","article-title":"How the immune system shapes atherosclerosis: roles of innate and adaptive immunity","volume":"22","author":"Roy","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2026.117116_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2017.00072","article-title":"Diabetic cardiomyopathy: an immunometabolic perspective","volume":"8","author":"Mishra","year":"2017","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.intimp.2026.117116_bb0065","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.3389\/fphys.2018.01547","article-title":"The role of leukocytes in diabetic cardiomyopathy","volume":"9","author":"Bajpai","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.intimp.2026.117116_bb0070","doi-asserted-by":"crossref","unstructured":"Filardi T, Ghinassi B, Di Baldassarre A, et al. Cardiomyopathy associated with diabetes: the central role of the cardiomyocyte. Int. J. Mol. Sci. 2019;20(13):3299. doi:https:\/\/doi.org\/10.3390\/ijms20133299.","DOI":"10.3390\/ijms20133299"},{"issue":"12","key":"10.1016\/j.intimp.2026.117116_bb0075","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCULATIONAHA.120.046464","article-title":"Hyperglycemia induces trained immunity in macrophages and their precursors and promotes atherosclerosis","volume":"144","author":"Edgar","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2026.117116_bb0080","doi-asserted-by":"crossref","DOI":"10.34133\/research.0365","article-title":"Diabetes primes neutrophils for neutrophil extracellular trap formation through trained immunity","volume":"7","author":"Shrestha","year":"2024","journal-title":"Research"},{"issue":"5","key":"10.1016\/j.intimp.2026.117116_bb0085","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","article-title":"Trained immunity: a memory for innate host defense","volume":"9","author":"Netea","year":"2011","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.intimp.2026.117116_bb0090","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1177\/2047487314529350","article-title":"Inflammation modulation and cardiovascular disease prevention","volume":"22","author":"Awan","year":"2015","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.intimp.2026.117116_bb0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-pathmechdis-012418-013003","article-title":"Innate immune signaling in nonalcoholic fatty liver disease and cardiovascular diseases","volume":"14","author":"Cai","year":"2019","journal-title":"Annu. Rev. Pathol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117116_bb0100","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","article-title":"The inflammatory response in myocardial injury, repair, and remodelling","volume":"11","author":"Frangogiannis","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117116_bb0105","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/eurheartj\/ehad787","article-title":"Myocardial infarction drives trained immunity of monocytes, accelerating atherosclerosis","volume":"45","author":"Dong","year":"2024","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.intimp.2026.117116_bb0110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.coph.2010.01.006","article-title":"Role of the adaptive immune system in hypertension","volume":"10","author":"Harrison","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117116_bb0115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/18756212MTA3yNzEe1","article-title":"The innate immune system and cardiovascular disease in ESKD: monocytes and natural killer cells","volume":"19","author":"Dounousi","year":"2021","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117116_bb0120","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.cell.2017.03.050","article-title":"Macrophages facilitate electrical conduction in the heart","volume":"169","author":"Hulsmans","year":"2017","journal-title":"Cell"},{"issue":"18","key":"10.1016\/j.intimp.2026.117116_bb0125","doi-asserted-by":"crossref","DOI":"10.1172\/JCI171953","article-title":"Cardiac macrophages and emerging roles for their metabolism after myocardial infarction","volume":"133","author":"Thorp","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2026.117116_bb0130","article-title":"The role of IL-1 family cytokines in diabetic cardiomyopathy","author":"Wu","year":"2024","journal-title":"Metabolism"},{"issue":"24","key":"10.1016\/j.intimp.2026.117116_bb0135","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1161\/CIRCULATIONAHA.109.893248","article-title":"Regulatory T cells protect mice against coxsackievirus-induced myocarditis through the transforming growth factor beta-coxsackie-adenovirus receptor pathway","volume":"121","author":"Shi","year":"2010","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.intimp.2026.117116_bb0140","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.immuni.2017.10.011","article-title":"A CD103+ conventional dendritic cell surveillance system prevents development of overt heart failure during subclinical viral myocarditis","volume":"47","author":"Clemente-Casares","year":"2017","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.intimp.2026.117116_bb0145","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1161\/01.CIR.0000117090.01718.2A","article-title":"Mortality in patients after a recent myocardial infarction","volume":"109","author":"Camm","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.intimp.2026.117116_bb0150","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrcardio.2015.169","article-title":"Regulatory T cells in cardiovascular diseases","volume":"13","author":"Meng","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117116_bb0155","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/CIRCULATIONAHA.118.035235","article-title":"Loss of gut microbiota alters immune system composition and cripples Postinfarction cardiac repair","volume":"139","author":"Tang","year":"2019","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.intimp.2026.117116_bb0160","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41569-021-00646-w","article-title":"Transforming growth factor-\u03b2 in myocardial disease","volume":"19","author":"Frangogiannis","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.intimp.2026.117116_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115342","article-title":"Modulating the immune system towards a functional chronic wound healing: a biomaterials and nanomedicine perspective","volume":"210","author":"Las Heras","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.intimp.2026.117116_bb0170","doi-asserted-by":"crossref","unstructured":"Shapiro MR, Dong X, Perry DJ, et al. Human immune phenotyping reveals accelerated aging in type 1 diabetes. JCI Insight 8(17):e170767. doi:https:\/\/doi.org\/10.1172\/jci.insight.170767.","DOI":"10.1172\/jci.insight.170767"},{"issue":"13","key":"10.1016\/j.intimp.2026.117116_bb0175","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.3390\/ijms25137105","article-title":"Pathology of diabetes-induced immune dysfunction","volume":"25","author":"Alexander","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2026.117116_bb0180","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2026.117116_bb0185","article-title":"Trained immunity in monocyte\/macrophage: novel mechanism of phytochemicals in the treatment of atherosclerotic cardiovascular disease","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2026.117116_bb0190","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1161\/ATVBAHA.114.303887","article-title":"Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes","volume":"34","author":"Bekkering","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"95","key":"10.1016\/j.intimp.2026.117116_bb0195","doi-asserted-by":"crossref","first-page":"eade3814","DOI":"10.1126\/sciimmunol.ade3814","article-title":"Heart failure promotes multimorbidity through innate immune memory","volume":"9","author":"Nakayama","year":"2024","journal-title":"Sci. Immunol."},{"issue":"17","key":"10.1016\/j.intimp.2026.117116_bb0200","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1016\/j.cell.2024.06.028","article-title":"Innate immune memory after brain injury drives inflammatory cardiac dysfunction","volume":"187","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2026.117116_bb0205","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41581-022-00633-5","article-title":"Trained immunity - basic concepts and contributions to immunopathology","volume":"19","author":"Ochando","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117116_bb0210","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41569-023-00894-y","article-title":"Trained immunity in atherosclerotic cardiovascular disease","volume":"20","author":"Riksen","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117116_bb0215","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s00395-007-0673-0","article-title":"Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy","volume":"102","author":"Westermann","year":"2007","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.intimp.2026.117116_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2024.108136","article-title":"Single-cell transcriptome sequencing revealed the metabolic changes and microenvironment changes of cardiomyocytes induced by diabetes","volume":"112","author":"Zhou","year":"2024","journal-title":"Comput. Biol. Chem."},{"issue":"4","key":"10.1016\/j.intimp.2026.117116_bb0225","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/cvr\/cvx011","article-title":"An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy","volume":"113","author":"Frati","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.intimp.2026.117116_bb0230","article-title":"Single-cell RNA-seq of heart reveals intercellular communication drivers of myocardial fibrosis in diabetic cardiomyopathy","volume":"12","author":"Li","year":"2023","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.intimp.2026.117116_bb0235","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-024-02195-1","article-title":"Persistent epigenetic signals propel a senescence-associated secretory phenotype and trained innate immunity in CD34+ hematopoietic stem cells from diabetic patients","volume":"23","author":"Vinci","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117116_bb0240","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.cmet.2013.04.001","article-title":"Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis","volume":"17","author":"Nagareddy","year":"2013","journal-title":"Cell Metab."},{"issue":"11","key":"10.1016\/j.intimp.2026.117116_bb0245","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301078R","article-title":"Trained immunity in diabetes and hyperlipidemia: emerging opportunities to target cardiovascular complications and design new therapies","volume":"37","author":"Robinson","year":"2023","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.intimp.2026.117116_bb0250","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1084\/jem.20150900","article-title":"The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease","volume":"213","author":"Shirai","year":"2016","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.117116_bb0255","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/ATVBAHA.120.314211","article-title":"Diabetes and metabolic drivers of trained immunity: new therapeutic targets beyond glucose","volume":"41","author":"Choudhury","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117116_bb0260","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.2337\/diacare.24.9.1614","article-title":"Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors","volume":"24","author":"Nichols","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.intimp.2026.117116_bb0265","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.2147\/IJN.S138400","article-title":"Gold nanoparticle-based miR155 antagonist macrophage delivery restores the cardiac function in ovariectomized diabetic mouse model","volume":"12","author":"Jia","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.intimp.2026.117116_bb0270","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3389\/fphys.2018.00453","article-title":"Diabetic cardiomyopathy: impact of biological sex on disease development and molecular signatures","volume":"9","author":"Toedebusch","year":"2018","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117116_bb0275","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.intimp.2026.117116_bb0280","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/cei.13344","article-title":"Type 2 diabetes is associated with the accumulation of senescent T cells","volume":"197","author":"Lau","year":"2019","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2026.117116_bb0285","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3389\/fimmu.2017.00982","article-title":"Immunobiography and the heterogeneity of immune responses in the elderly: a focus on Inflammaging and trained immunity","volume":"8","author":"Franceschi","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117116_bb0290","article-title":"Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets","volume":"9","author":"Chen","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.intimp.2026.117116_bb0295","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/cvr\/cvz336","article-title":"Cardiac monocytes and macrophages after myocardial infarction","volume":"116","author":"Peet","year":"2020","journal-title":"Cardiovasc. Res."},{"issue":"9","key":"10.1016\/j.intimp.2026.117116_bb0300","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/0167-5699(96)10029-3","article-title":"Heterogeneity of human blood monocytes: the CD14CD16 subpopulation++","volume":"17","author":"Ziegler-Heitbrock","year":"1996","journal-title":"Immunol. Today"},{"issue":"3","key":"10.1016\/j.intimp.2026.117116_bb0305","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1182\/blood-2009-07-235028","article-title":"Comparison of gene expression profiles between human and mouse monocyte subsets","volume":"115","author":"Ingersoll","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.intimp.2026.117116_bb0310","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.immuni.2013.08.007","article-title":"Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes","volume":"39","author":"Jakubzick","year":"2013","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2026.117116_bb0315","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.immuni.2013.11.019","article-title":"Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation","volume":"40","author":"Epelman","year":"2014","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.intimp.2026.117116_bb0320","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/s41591-018-0059-x","article-title":"The human heart contains distinct macrophage subsets with divergent origins and functions","volume":"24","author":"Bajpai","year":"2018","journal-title":"Nat. Med."},{"issue":"7966","key":"10.1016\/j.intimp.2026.117116_bb0325","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/s41586-023-06002-x","article-title":"Physiology and diseases of tissue-resident macrophages","volume":"618","author":"Lazarov","year":"2023","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.intimp.2026.117116_bb0330","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41569-022-00823-5","article-title":"Macrophages in cardiac remodelling after myocardial infarction","volume":"20","author":"Yap","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117116_bb0335","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1161\/CIRCRESAHA.121.319737","article-title":"Cardiac resident macrophages prevent fibrosis and stimulate angiogenesis","volume":"129","author":"Revelo","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2026.117116_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01462","article-title":"The metabolic signature of macrophage responses","volume":"10","author":"Viola","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2026.117116_bb0345","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/CIRCRESAHA.119.312321","article-title":"Obesity, hypertension, and cardiac dysfunction: novel roles of Immunometabolism in macrophage activation and inflammation","volume":"126","author":"Mouton","year":"2020","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.intimp.2026.117116_bb0350","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.3390\/ijms22052715","article-title":"Macrophage polarization in cardiac tissue repair following myocardial infarction","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.117116_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111858","article-title":"Interleukin-1\u03b2 polarization in M1 macrophage mediates myocardial fibrosis in diabetes","volume":"131","author":"Guo","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117116_bb0360","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00395-017-0622-5","article-title":"IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation","volume":"112","author":"Jung","year":"2017","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.intimp.2026.117116_bb0365","doi-asserted-by":"crossref","unstructured":"Li L, Cao J, Li S, et al. M2 macrophage-derived sEV regulate pro-inflammatory CCR2+ macrophage subpopulations to favor post-AMI cardiac repair. Adv. Sci. 2023;10(14):2202964. doi:https:\/\/doi.org\/10.1002\/advs.202202964.","DOI":"10.1002\/advs.202202964"},{"issue":"10","key":"10.1016\/j.intimp.2026.117116_bb0370","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.3390\/cells10102640","article-title":"BMP-7 attenuates inflammation-induced Pyroptosis and improves cardiac repair in diabetic cardiomyopathy","volume":"10","author":"Elmadbouh","year":"2021","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.intimp.2026.117116_bb0375","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12933-021-01303-9","article-title":"Diastolic dysfunction in a pre-clinical model of diabetes is associated with changes in the cardiac non-myocyte cellular composition","volume":"20","author":"Cohen","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117116_bb0380","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1084\/jem.20081188","article-title":"Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia","volume":"205","author":"El-Osta","year":"2008","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.117116_bb0385","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4049\/jimmunol.1901348","article-title":"Hyperglycemic memory of innate immune cells promotes in vitro Proinflammatory responses of human monocytes and murine macrophages","volume":"206","author":"Thiem","year":"2021","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117116_bb0390","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cyto.2013.08.003","article-title":"Convergence of innate immunity and insulin resistance as evidenced by increased nucleotide oligomerization domain (NOD) expression and signaling in monocytes from patients with type 2 diabetes","volume":"64","author":"Shiny","year":"2013","journal-title":"Cytokine"},{"issue":"12","key":"10.1016\/j.intimp.2026.117116_bb0395","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1042\/CS20140180","article-title":"NOD1 receptor is up-regulated in diabetic human and murine myocardium","volume":"127","author":"Prieto","year":"2014","journal-title":"Clin. Sci. (Lond.)"},{"issue":"9","key":"10.1016\/j.intimp.2026.117116_bb0400","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.3390\/biomedicines9091139","article-title":"Normalizing HIF-1\u03b1 signaling improves cellular glucose metabolism and blocks the pathological pathways of hyperglycemic damage","volume":"9","author":"Iacobini","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.intimp.2026.117116_bb0405","doi-asserted-by":"crossref","unstructured":"Liu Y, Lei Y, Dai Z, et al. Trained immunity: novel perspectives in diabetes and associated complications. Front. Immunol. 2025;16:1613602. doi:https:\/\/doi.org\/10.3389\/fimmu.2025.1613602.","DOI":"10.3389\/fimmu.2025.1613602"},{"issue":"6","key":"10.1016\/j.intimp.2026.117116_bb0410","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.cmet.2016.10.008","article-title":"Glutaminolysis and fumarate accumulation integrate Immunometabolic and epigenetic programs in trained immunity","volume":"24","author":"Arts","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2026.117116_bb0415","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.trsl.2021.05.006","article-title":"Macrophage polarization and diabetic wound healing","volume":"236","author":"Louiselle","year":"2021","journal-title":"Transl. Res."},{"issue":"2","key":"10.1016\/j.intimp.2026.117116_bb0420","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1042\/CS20180905","article-title":"Trained immunity and diabetic vascular disease","volume":"133","author":"Thiem","year":"2019","journal-title":"Clin. Sci. (Lond.)"},{"issue":"1","key":"10.1016\/j.intimp.2026.117116_bb0425","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.kint.2017.02.013","article-title":"Beta 2-adrenergic receptor agonists are novel regulators of macrophage activation in diabetic renal and cardiovascular complications","volume":"92","author":"Noh","year":"2017","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.intimp.2026.117116_bb0430","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126580","article-title":"Chronic inhibition of PDE5 limits pro-inflammatory monocyte-macrophage polarization in Streptozotocin-induced diabetic mice","volume":"10","author":"Venneri","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.intimp.2026.117116_bb0435","first-page":"C570","article-title":"Epigenetic modifications in metabolic memory: what are the memories, and can we erase them?","volume":"323","author":"Chen","year":"2022","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"11","key":"10.1016\/j.intimp.2026.117116_bb0440","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.2337\/db18-1231","article-title":"Role of CCR2 in the development of Streptozotocin-treated diabetic cardiomyopathy","volume":"68","author":"Tan","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2026.117116_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118989","article-title":"The effect of miR-471-3p on macrophage polarization in the development of diabetic cardiomyopathy","volume":"268","author":"Liu","year":"2021","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.intimp.2026.117116_bb0450","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220577","article-title":"Hyperglycemia acts in synergy with hypoxia to maintain the pro-inflammatory phenotype of macrophages","volume":"14","author":"Morey","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2026.117116_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119116","article-title":"Inhibition of SGLT1 protects against glycemic variability-induced cardiac damage and pyroptosis of cardiomyocytes in diabetic mice","volume":"271","author":"Sun","year":"2021","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.intimp.2026.117116_bb0460","doi-asserted-by":"crossref","DOI":"10.1128\/mcb.00282-21","article-title":"Inhibition of SGLT1 alleviates the glycemic variability-induced cardiac fibrosis via inhibition of activation of macrophage and cardiac fibroblasts","volume":"42","author":"Wu","year":"2022","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117116_bb0465","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.gendis.2023.03.029","article-title":"High glucose promotes macrophage M1 polarization through miR-32\/Mef2d\/cAMP signaling pathway","volume":"11","author":"Chen","year":"2024","journal-title":"Genes & Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.117116_bb0470","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cardiores.2006.10.009","article-title":"Adiponectin actions in the cardiovascular system","volume":"74","author":"Hopkins","year":"2007","journal-title":"Cardiovasc. Res."},{"issue":"9","key":"10.1016\/j.intimp.2026.117116_bb0475","doi-asserted-by":"crossref","first-page":"6153","DOI":"10.1074\/jbc.M109.088708","article-title":"Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype","volume":"285","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.intimp.2026.117116_bb0480","doi-asserted-by":"crossref","first-page":"13460","DOI":"10.1074\/jbc.M110.204644","article-title":"Molecular mechanism for adiponectin-dependent M2 macrophage polarization: LINK BETWEEN THE METABOLIC AND INNATE IMMUNE ACTIVITY OF FULL-LENGTH ADIPONECTIN","volume":"286","author":"Mandal","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.intimp.2026.117116_bb0485","doi-asserted-by":"crossref","DOI":"10.1210\/en.2013-2011","article-title":"Adiponectin suppresses angiotensin II-induced inflammation and cardiac fibrosis through activation of macrophage autophagy","volume":"155","author":"Qi","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.intimp.2026.117116_bb0490","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/s41467-020-15978-3","article-title":"MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.intimp.2026.117116_bb0495","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/CIRCULATIONAHA.118.036044","article-title":"Dectin-1 contributes to myocardial ischemia\/reperfusion injury by regulating macrophage polarization and neutrophil infiltration","volume":"139","author":"Fan","year":"2019","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.intimp.2026.117116_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166710","article-title":"Dectin-1 deficiency alleviates diabetic cardiomyopathy by attenuating macrophage-mediated inflammatory response","volume":"1869","author":"Yang","year":"2023","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"issue":"8","key":"10.1016\/j.intimp.2026.117116_bb0505","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/ni.2063","article-title":"The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes","volume":"12","author":"Hanna","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2026.117116_bb0510","article-title":"Loss of Lipocalin 10 exacerbates diabetes-induced cardiomyopathy via disruption of Nr4a1-mediated anti-inflammatory response in macrophages","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117116_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2021.104279","article-title":"NR4A2 alleviates cardiomyocyte loss and myocardial injury in rats by transcriptionally suppressing CCR5 and inducing M2 polarization of macrophages","volume":"140","author":"Miao","year":"2022","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.intimp.2026.117116_bb0520","doi-asserted-by":"crossref","unstructured":"Zheng Y, Xu Y, Ji L, et al. Roles of distinct nuclear receptors in diabetic cardiomyopathy. Front. Pharmacol. 2024;15. doi:https:\/\/doi.org\/10.3389\/fphar.2024.1423124.","DOI":"10.3389\/fphar.2024.1423124"},{"issue":"10","key":"10.1016\/j.intimp.2026.117116_bb0525","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102659","article-title":"Replacement of lost substance P reduces fibrosis in the diabetic heart by preventing adverse fibroblast and macrophage phenotype changes","volume":"10","author":"Widiapradja","year":"2021","journal-title":"Cells"},{"issue":"18","key":"10.1016\/j.intimp.2026.117116_bb0530","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1161\/CIRCULATIONAHA.118.035047","article-title":"IL (interleukin)-10-STAT3-Galectin-3 Axis is essential for Osteopontin-producing reparative macrophage polarization after myocardial infarction","volume":"138","author":"Shirakawa","year":"2018","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.intimp.2026.117116_bb0535","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ptr.6217","article-title":"Berberine alleviates oxidized low-density lipoprotein-induced macrophage activation by downregulating galectin-3 via the NF-\u03baB and AMPK signaling pathways","volume":"33","author":"Pei","year":"2019","journal-title":"Phytother. Res."},{"key":"10.1016\/j.intimp.2026.117116_bb0540","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.868372","article-title":"Galectin-3 inhibition ameliorates Streptozotocin-induced diabetic cardiomyopathy in mice","volume":"9","author":"Zhu","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"2","key":"10.1016\/j.intimp.2026.117116_bb0545","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1161\/CIRCRESAHA.118.314028","article-title":"Tissue resident CCR2\u2212 and CCR2+ cardiac macrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury","volume":"124","author":"Bajpai","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2026.117116_bb0550","doi-asserted-by":"crossref","unstructured":"Monnerat G, Alarc\u00f3n ML, Vasconcellos LR, et al. Macrophage-dependent IL-1\u03b2 production induces cardiac arrhythmias in diabetic mice. Nat. Commun. 2016;7:13344. doi:https:\/\/doi.org\/10.1038\/ncomms13344.","DOI":"10.1038\/ncomms13344"},{"issue":"8","key":"10.1016\/j.intimp.2026.117116_bb0555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042507","article-title":"Classical macrophage activation up-regulates several matrix metalloproteinases through mitogen activated protein kinases and nuclear factor-\u03baB","volume":"7","author":"Huang","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.intimp.2026.117116_bb0560","first-page":"H802","article-title":"Antifibrotic cardioprotection of berberine via downregulating myocardial IGF-1 receptor-regulated MMP-2\/MMP-9 expression in diabetic rats","volume":"315","author":"Li","year":"2018","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"issue":"6818","key":"10.1016\/j.intimp.2026.117116_bb0565","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35053000","article-title":"The hormone resistin links obesity to diabetes","volume":"409","author":"Steppan","year":"2001","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.intimp.2026.117116_bb0570","first-page":"387","article-title":"Diabetic cardiomyopathy: is resistin a culprit?","volume":"5","author":"Lebeche","year":"2015","journal-title":"Cardiovasc Diagn Ther."},{"issue":"2","key":"10.1016\/j.intimp.2026.117116_bb0575","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1096\/fj.201901995R","article-title":"Targeting exosome-associated human antigen R attenuates fibrosis and inflammation in diabetic heart","volume":"34","author":"Govindappa","year":"2020","journal-title":"FASEB J."},{"issue":"25","key":"10.1016\/j.intimp.2026.117116_bb0580","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1016\/j.jacc.2019.10.036","article-title":"Transition of macrophages to fibroblast-like cells in healing myocardial infarction","volume":"74","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.intimp.2026.117116_bb0585","doi-asserted-by":"crossref","DOI":"10.1038\/srep36207","article-title":"MicroRNA-126 overexpression rescues diabetes-induced impairment in efferocytosis of apoptotic cardiomyocytes","volume":"6","author":"Suresh Babu","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.intimp.2026.117116_bb0590","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","article-title":"Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients","volume":"20","author":"Hotta","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2026.117116_bb0595","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.intimp.2026.117116_bb0600","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nm.1994","article-title":"Deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice","volume":"15","author":"Liu","year":"2009","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117116_bb0605","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2012.04.038","article-title":"High glucose increases the expression of proinflammatory cytokines and secretion of TNF\u03b1 and \u03b2-hexosaminidase in human mast cells","volume":"687","author":"Nagai","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117116_bb0610","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1038\/s41418-018-0071-1","article-title":"Monoamine oxidase-dependent endoplasmic reticulum-mitochondria dysfunction and mast cell degranulation lead to adverse cardiac remodeling in diabetes","volume":"25","author":"Deshwal","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.intimp.2026.117116_bb0615","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2019.01.005","article-title":"Mast cell-deficiency protects mice from streptozotocin-induced diabetic cardiomyopathy","volume":"208","author":"He","year":"2019","journal-title":"Transl. Res."},{"key":"10.1016\/j.intimp.2026.117116_bb0620","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2012.00007","article-title":"Different roles of mast cells in obesity and diabetes: lessons from experimental animals and humans","volume":"3","author":"Shi","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117116_bb0625","doi-asserted-by":"crossref","unstructured":"Li Y, Liu B, Li Y, et al. Epicardial fat tissue in patients with diabetes mellitus: a systematic review and meta-analysis. Cardiovasc. Diabetol. 2019;18(1):3. doi:https:\/\/doi.org\/10.1186\/s12933-019-0807-3.","DOI":"10.1186\/s12933-019-0807-3"},{"issue":"20","key":"10.1016\/j.intimp.2026.117116_bb0630","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2018.03.509","article-title":"Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium","volume":"71","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.intimp.2026.117116_bb0635","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1161\/ATVBAHA.121.315900","article-title":"Mast cells are the trigger of small vessel disease and diastolic dysfunction in diabetic obese mice","volume":"41","author":"Guimbal","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1\u20133","key":"10.1016\/j.intimp.2026.117116_bb0640","first-page":"1","article-title":"Therapeutic applications of chymase inhibitors in cardiovascular diseases and fibrosis","volume":"501","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117116_bb0645","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/HYPERTENSIONAHA.114.04238","article-title":"Estrogen inhibits mast cell Chymase release to prevent pressure overload-induced adverse cardiac remodeling","volume":"65","author":"Li","year":"2015","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.intimp.2026.117116_bb0650","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/eji.201545498","article-title":"Mast cells control insulitis and increase Treg cells to confer protection against STZ-induced type 1 diabetes in mice","volume":"45","author":"Carlos","year":"2015","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117116_bb0655","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-\u03b2: \u201cN1\u201d versus \u201cN2\u201d TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.intimp.2026.117116_bb0660","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.2147\/IJN.S458295","article-title":"HucMSC-Exo induced N2 polarization of neutrophils: implications for angiogenesis and tissue restoration in wound healing","volume":"19","author":"Yang","year":"2024","journal-title":"Int. J. Nanomedicine"},{"issue":"3","key":"10.1016\/j.intimp.2026.117116_bb0665","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3390\/cells13030208","article-title":"Anti-inflammatory neutrophils reprogram macrophages toward a pro-healing phenotype with increased Efferocytosis capacity","volume":"13","author":"Mihaila","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2026.117116_bb0670","doi-asserted-by":"crossref","unstructured":"Ministrini S, Andreozzi F, Montecucco F, et al. Neutrophil degranulation biomarkers characterize restrictive echocardiographic pattern with diastolic dysfunction in patients with diabetes. Eur. J. Clin. Investig. 2021;51(12):e13640. doi:https:\/\/doi.org\/10.1111\/eci.13640.","DOI":"10.1111\/eci.13640"},{"issue":"1","key":"10.1016\/j.intimp.2026.117116_bb0675","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12902-020-00571-y","article-title":"Neutrophil: lymphocyte ratio is positively associated with subclinical diabetic cardiomyopathy","volume":"20","author":"Huang","year":"2020","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.intimp.2026.117116_bb0680","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41392-023-01497-2","article-title":"Interaction between neutrophil extracellular traps and cardiomyocytes contributes to atrial fibrillation progression","volume":"8","author":"He","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.intimp.2026.117116_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117289","article-title":"The pivotal role of neutrophil extracellular traps in cardiovascular diseases: mechanisms and therapeutic implications","volume":"179","author":"Geng","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.intimp.2026.117116_bb0690","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.011057","article-title":"Neutrophil extracellular traps in myocardial tissue drive cardiac dysfunction and adverse outcomes in patients with heart failure with dilated cardiomyopathy","volume":"17","author":"Ichimura","year":"2024","journal-title":"Circ. Heart Fail."},{"issue":"3","key":"10.1016\/j.intimp.2026.117116_bb0695","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00592-014-0676-x","article-title":"NETosis is induced by high glucose and associated with type 2 diabetes","volume":"52","author":"Menegazzo","year":"2015","journal-title":"Acta Diabetol."},{"issue":"7","key":"10.1016\/j.intimp.2026.117116_bb0700","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nm.3887","article-title":"Diabetes primes neutrophils to undergo NETosis, which impairs wound healing","volume":"21","author":"Wong","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2026.117116_bb0705","doi-asserted-by":"crossref","first-page":"16457","DOI":"10.1038\/s41598-024-67281-6","article-title":"Neutrophil extracellular traps promote erectile dysfunction in rats with diabetes mellitus by enhancing NLRP3-mediated pyroptosis","volume":"14","author":"Xu","year":"2024","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.intimp.2026.117116_bb0710","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000444881","article-title":"Circulating neutrophil extracellular trap levels in well-controlled type 2 diabetes and pathway involved in their formation induced by high-dose glucose","volume":"83","author":"Miyoshi","year":"2016","journal-title":"Pathobiology"},{"key":"10.1016\/j.intimp.2026.117116_bb0715","doi-asserted-by":"crossref","unstructured":"Cheng SC, Quintin J, Cramer RA, et al. mTOR\/HIF1\u03b1-mediated aerobic glycolysis as metabolic basis for trained immunity. Science 2014;345(6204):1250684. doi:https:\/\/doi.org\/10.1126\/science.1250684.","DOI":"10.1126\/science.1250684"},{"issue":"6","key":"10.1016\/j.intimp.2026.117116_bb0720","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.118.038820","article-title":"Wnt5a-mediated neutrophil recruitment has an obligatory role in pressure overload\u2013induced cardiac dysfunction","author":"Wang","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2026.117116_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174623","article-title":"Inhibition of PAD4-mediated NET formation by cl-amidine prevents diabetes development in nonobese diabetic mice","volume":"916","author":"Shen","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"37","key":"10.1016\/j.intimp.2026.117116_bb0730","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1093\/eurheartj\/ehae517","article-title":"Von Willebrand factor exacerbates heart failure through formation of neutrophil extracellular traps","volume":"45","author":"Mang","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.intimp.2026.117116_bb0735","doi-asserted-by":"crossref","unstructured":"Zhao X, Zhang J, Xu F, Shang L, Liu Q, Shen C. TAK-242 alleviates diabetic cardiomyopathy via inhibiting pyroptosis and TLR4\/CaMKII\/NLRP3 pathway. Open Life Sci. 2024;19(1). doi:https:\/\/doi.org\/10.1515\/biol-2022-0957.","DOI":"10.1515\/biol-2022-0957"},{"key":"10.1016\/j.intimp.2026.117116_bb0740","doi-asserted-by":"crossref","unstructured":"Schommer N, Sheehy C, Van Bruggen S, et al. Abstract 4140304: protein Arginin deiminase 4 deficiency prevents Streptozotocin-induced diabetic cardiomyopathy and heart failure with reduced NLRP3 (nucleotide-binding domain-like receptor protein 3) inflammasome activation. Circulation 2024;150(Suppl_1):A4140304-A4140304. doi:https:\/\/doi.org\/10.1161\/circ.150.suppl_1.4140304.","DOI":"10.1161\/circ.150.suppl_1.4140304"},{"issue":"2","key":"10.1016\/j.intimp.2026.117116_bb0745","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.lfs.2014.09.015","article-title":"The heterogenic properties of monocytes\/macrophages and neutrophils in inflammatory response in diabetes","volume":"116","author":"Rao","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2026.117116_bb0750","doi-asserted-by":"crossref","unstructured":"Horckmans M, Ring L, Duchene J, et al. Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype. Eur. Heart J. 2017;38(3):187\u2013197. doi:https:\/\/doi.org\/10.1093\/eurheartj\/ehw002.","DOI":"10.1093\/eurheartj\/ehw002"},{"issue":"9","key":"10.1016\/j.intimp.2026.117116_bb0755","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1093\/cvr\/cvab269","article-title":"EDIL3 deficiency ameliorates adverse cardiac remodelling by neutrophil extracellular traps (NET)-mediated macrophage polarization","volume":"118","author":"Wei","year":"2022","journal-title":"Cardiovasc. Res."},{"issue":"10","key":"10.1016\/j.intimp.2026.117116_bb0760","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1096\/fj.201800231R","article-title":"Targeted deletion of T-cell S1P receptor 1 ameliorates cardiac fibrosis in streptozotocin-induced diabetic mice","volume":"32","author":"Abdullah","year":"2018","journal-title":"FASEB J."},{"issue":"23","key":"10.1016\/j.intimp.2026.117116_bb0765","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1097\/CM9.0000000000002875","article-title":"Regulatory T cells and cardiovascular diseases","volume":"136","author":"Hu","year":"2023","journal-title":"Chin. Med. J."},{"issue":"1","key":"10.1016\/j.intimp.2026.117116_bb0770","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.cyto.2014.09.011","article-title":"T cell subsets and their signature cytokines in autoimmune and inflammatory diseases","volume":"74","author":"Raphael","year":"2015","journal-title":"Cytokine"},{"issue":"2","key":"10.1016\/j.intimp.2026.117116_bb0775","doi-asserted-by":"crossref","first-page":"H264","DOI":"10.1152\/ajpheart.00123.2019","article-title":"The adaptive immune role of metallothioneins in the pathogenesis of diabetic cardiomyopathy: good or bad","volume":"317","author":"Ge","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117116_bb0780","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.4049\/jimmunol.1401125","article-title":"Chromatin Decondensation and T cell Hyperresponsiveness in diabetes-associated hyperglycemia","volume":"193","author":"Martinez","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2026.117116_bb0785","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.intimp.2016.07.027","article-title":"Depletion of T lymphocytes ameliorates cardiac fibrosis in streptozotocin-induced diabetic cardiomyopathy","volume":"39","author":"Abdullah","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2026.117116_bb0790","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.879522","article-title":"Cell-target-specific anti-inflammatory effect of Empagliflozin: in vitro evidence in human cardiomyocytes","volume":"9","author":"Giannattasio","year":"2022","journal-title":"Front. Mol. Biosci."},{"issue":"3","key":"10.1016\/j.intimp.2026.117116_bb0795","first-page":"1238","article-title":"Phosphodiesterase type 5 inhibitor sildenafil decreases the Proinflammatory chemokine CXCL10 in human cardiomyocytes and in subjects with diabetic cardiomyopathy","volume":"39","author":"Di Luigi","year":"2016","journal-title":"Inflammation"},{"issue":"6","key":"10.1016\/j.intimp.2026.117116_bb0800","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1006\/jaut.1998.0240","article-title":"Decreased secretion of Th2 cytokines precedes up-regulated and delayed secretion of Th1 cytokines in activated peripheral blood mononuclear cells from patients with insulin-dependent diabetes mellitus","volume":"11","year":"1998","journal-title":"J. Autoimmun."},{"issue":"10","key":"10.1016\/j.intimp.2026.117116_bb0805","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.4239\/wjd.v15.i10.2093","article-title":"Identification of immune feature genes and intercellular profiles in diabetic cardiomyopathy","volume":"15","author":"Zheng","year":"2024","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.intimp.2026.117116_bb0810","doi-asserted-by":"crossref","unstructured":"Zhao R xing, Li W juan, Lu Y ran, et al. Increased peripheral proinflammatory T helper subsets contribute to cardiovascular complications in diabetic patients. Mediat. Inflamm. 2014;2014:596967. doi:https:\/\/doi.org\/10.1155\/2014\/596967.","DOI":"10.1155\/2014\/596967"},{"issue":"7","key":"10.1016\/j.intimp.2026.117116_bb0815","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.4049\/jimmunol.1001860","article-title":"Cutting edge: increased IL-17-secreting T cells in children with new-onset type 1 diabetes","volume":"185","author":"Marwaha","year":"2010","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2026.117116_bb0820","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071905","article-title":"Increased systemic Th17 cytokines are associated with diastolic dysfunction in children and adolescents with diabetic ketoacidosis","volume":"8","author":"Hoffman","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2026.117116_bb0825","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5512322","article-title":"Ketogenic diet suppressed T-regulatory cells and promoted cardiac fibrosis via reducing mitochondria-associated membranes and inhibiting mitochondrial function","volume":"2021","author":"Tao","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"20","key":"10.1016\/j.intimp.2026.117116_bb0830","doi-asserted-by":"crossref","first-page":"8924","DOI":"10.7150\/thno.47118","article-title":"An emerging role of regulatory T-cells in cardiovascular repair and regeneration","volume":"10","author":"Fung","year":"2020","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.intimp.2026.117116_bb0835","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrcardio.2015.169","article-title":"Regulatory T cells in cardiovascular diseases","volume":"13","author":"Meng","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117116_bb0840","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1253\/circj.CJ-19-1182","article-title":"Sustaining circulating regulatory T cell subset contributes to the therapeutic effect of paroxetine on mice with diabetic cardiomyopathy","volume":"84","author":"Han","year":"2020","journal-title":"Circ. J."},{"issue":"5","key":"10.1016\/j.intimp.2026.117116_bb0845","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s12012-025-09982-6","article-title":"Downregulation of HSPB1 and MGST1 promotes Ferroptosis and impacts immune infiltration in diabetic cardiomyopathy","volume":"25","author":"Xie","year":"2025","journal-title":"Cardiovasc. Toxicol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117116_bb0850","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/jdi.14251","article-title":"Regulatory T cells protect against diabetic cardiomyopathy in db\/db mice","volume":"15","author":"Zhang","year":"2024","journal-title":"J. Diabetes Investigation."},{"issue":"6","key":"10.1016\/j.intimp.2026.117116_bb0855","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.immuni.2009.03.019","article-title":"Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor","volume":"30","year":"2009","journal-title":"Immunity"},{"issue":"49","key":"10.1016\/j.intimp.2026.117116_bb0860","doi-asserted-by":"crossref","first-page":"19446","DOI":"10.1073\/pnas.0706832104","article-title":"CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes\/macrophages","volume":"104","author":"Tiemessen","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2026.117116_bb0865","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.intimp.2026.117116_bb0870","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.118.038868","article-title":"Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus","volume":"139","author":"Zelniker","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.intimp.2026.117116_bb0875","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12933-023-01816-5","article-title":"Insights into SGLT2 inhibitor treatment of diabetic cardiomyopathy: focus on the mechanisms","volume":"22","author":"Huang","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.intimp.2026.117116_bb0880","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1163288","article-title":"GLP-1 RAs and SGLT2i: two antidiabetic agents associated with immune and inflammation modulatory properties through the common AMPK pathway","volume":"14","author":"Mazzieri","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.117116_bb0885","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.2147\/DDDT.S269514","article-title":"SGLT2 inhibitors: a novel player in the treatment and prevention of diabetic cardiomyopathy","volume":"14","author":"Li","year":"2020","journal-title":"Drug Des. Devel. Ther."},{"issue":"9","key":"10.1016\/j.intimp.2026.117116_bb0890","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.4239\/wjd.v15.i9.1847","article-title":"Macrophage modulation with dipeptidyl peptidase-4 inhibitors: a new frontier for treating diabetic cardiomyopathy?","volume":"15","author":"Mohammadi","year":"2024","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.intimp.2026.117116_bb0895","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12933-019-0816-2","article-title":"SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart","volume":"18","author":"Li","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117116_bb0900","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12933-016-0473-7","article-title":"Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome","volume":"15","author":"Kusaka","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.intimp.2026.117116_bb0905","doi-asserted-by":"crossref","unstructured":"Packer M, Anker SD, Butler J, et al. Cardiovascular and renal outcomes with Empagliflozin in heart failure. N. Engl. J. Med. Published online October 8, 2020. doi:https:\/\/doi.org\/10.1056\/NEJMoa2022190.","DOI":"10.1056\/NEJMoa2022190"},{"key":"10.1016\/j.intimp.2026.117116_bb0910","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","author":"JJV","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.117116_bb0915","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10557-020-06978-y","article-title":"Dapagliflozin and Ticagrelor have additive effects on the attenuation of the activation of the NLRP3 Inflammasome and the progression of diabetic cardiomyopathy: an AMPK-mTOR interplay","volume":"34","author":"Chen","year":"2020","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"2","key":"10.1016\/j.intimp.2026.117116_bb0920","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10557-017-6725-2","article-title":"SGLT-2 inhibition with Dapagliflozin reduces the activation of the Nlrp3\/ASC Inflammasome and attenuates the development of diabetic cardiomyopathy in mice with type 2 diabetes. Further augmentation of the effects with Saxagliptin, a DPP4 inhibitor","volume":"31","author":"Ye","year":"2017","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"1","key":"10.1016\/j.intimp.2026.117116_bb0925","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12933-019-0980-4","article-title":"Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy","volume":"19","author":"Arow","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"issue":"9","key":"10.1016\/j.intimp.2026.117116_bb0930","article-title":"Glucagon-like Peptide-1 (GLP-1) rescue diabetic cardiac Dysfuntions in human iPSC-derived cardiomyocytes","volume":"7","author":"Zhou","year":"2023","journal-title":"Adv. Biol. (Weinh)."},{"issue":"1","key":"10.1016\/j.intimp.2026.117116_bb0935","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ejhf.657","article-title":"Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial","volume":"19","author":"Jorsal","year":"2017","journal-title":"Eur. J. Heart Fail."},{"issue":"9","key":"10.1016\/j.intimp.2026.117116_bb0940","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","article-title":"Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence","volume":"17","author":"Tan","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.intimp.2026.117116_bb0945","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1399-543X.2004.00036.x","article-title":"The effect of immunomodulators on prevention of autoimmune diabetes is stage dependent: FTY720 prevents diabetes at three different stages in the diabetes-resistant biobreeding rat","volume":"5","author":"Popovic","year":"2004","journal-title":"Pediatr. Diabetes"},{"issue":"3","key":"10.1016\/j.intimp.2026.117116_bb0950","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/aps.2014.127","article-title":"Matrine pretreatment improves cardiac function in rats with diabetic cardiomyopathy via suppressing ROS\/TLR-4 signaling pathway","volume":"36","author":"Liu","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2026.117116_bb0955","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jep.2016.08.029","article-title":"Protective effects of triptolide on TLR4 mediated autoimmune and inflammatory response induced myocardial fibrosis in diabetic cardiomyopathy","volume":"193","author":"Guo","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2026.117116_bb0960","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s12872-024-04010-x","article-title":"Effect of NLRP3 gene knockdown on pyroptosis and ferroptosis in diabetic cardiomyopathy injury","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Cardiovasc. Disord."},{"issue":"11","key":"10.1016\/j.intimp.2026.117116_bb0965","first-page":"828","article-title":"The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction","volume":"38","author":"GPJ","year":"2017","journal-title":"Eur. Heart J."},{"issue":"59","key":"10.1016\/j.intimp.2026.117116_bb0970","doi-asserted-by":"crossref","first-page":"99740","DOI":"10.18632\/oncotarget.20763","article-title":"NLRP3-inflammasome inhibition prevents high fat and high sugar diets-induced heart damage through autophagy induction","volume":"8","author":"Pavillard","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.intimp.2026.117116_bb0975","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12933-015-0288-y","article-title":"Circulating interleukin-1\u03b2 promotes endoplasmic reticulum stress-induced myocytes apoptosis in diabetic cardiomyopathy via interleukin-1 receptor-associated kinase-2","volume":"14","author":"Liu","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117116_bb0980","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","article-title":"Anti-inflammatory therapy with Canakinumab for the prevention of hospitalization for heart failure","volume":"139","author":"Everett","year":"2019","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.intimp.2026.117116_bb0985","doi-asserted-by":"crossref","first-page":"8023","DOI":"10.1007\/s00210-024-03152-1","article-title":"Interleukin 1\u03b2 receptor blocker (Anakinra) and regenerative stem cell therapy: two novel approaches effectively ameliorating diabetic cardiomyopathy","volume":"397","author":"Mahmoud","year":"2024","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2026.117116_bb0990","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with Canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.intimp.2026.117116_bb0995","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1016\/j.jacc.2018.03.002","article-title":"Anti-inflammatory therapy with Canakinumab for the prevention and Management of Diabetes","volume":"71","author":"Everett","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"23","key":"10.1016\/j.intimp.2026.117116_bb1000","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.112.122556","article-title":"Effects of interleukin-1\u03b2 inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial","volume":"126","author":"Ridker","year":"2012","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.intimp.2026.117116_bb1005","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005036","article-title":"IL-1 blockade in patients with heart failure with preserved ejection fraction","volume":"11","author":"Van Tassell","year":"2018","journal-title":"Circ. Heart Fail."},{"issue":"7","key":"10.1016\/j.intimp.2026.117116_bb1010","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.4049\/jimmunol.167.7.4008","article-title":"Human mast cells release Metalloproteinase-9 on contact with activated T cells: Juxtacrine regulation by TNF-\u03b11","volume":"167","author":"Baram","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2026.117116_bb1015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1418897","article-title":"Mast cell stabilizers: from pathogenic roles to targeting therapies","volume":"15","author":"Cao","year":"2024","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2026.117116_bb1020","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","article-title":"Treg cell-based therapies: challenges and perspectives","volume":"20","author":"Raffin","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.117116_bb1025","doi-asserted-by":"crossref","DOI":"10.3390\/cells11020240","article-title":"Mesenchymal stem cell therapy in diabetic cardiomyopathy","volume":"11","author":"da Silva","year":"2022","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.intimp.2026.117116_bb1030","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/sctm.17-0130","article-title":"Placenta-derived adherent stromal cells improve diabetes mellitus-associated left ventricular diastolic performance","volume":"6","author":"Van Linthout","year":"2017","journal-title":"Stem Cells Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117116_bb1035","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12967-019-1999-8","article-title":"Mesenchymal stem cells promote type 2 macrophage polarization to ameliorate the myocardial injury caused by diabetic cardiomyopathy","volume":"17","author":"Jin","year":"2019","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.intimp.2026.117116_bb1040","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13287-020-01633-7","article-title":"Mesenchymal stem cells ameliorate myocardial fibrosis in diabetic cardiomyopathy via the secretion of prostaglandin E2","volume":"11","author":"Jin","year":"2020","journal-title":"Stem Cell Res. Ther."},{"issue":"11","key":"10.1016\/j.intimp.2026.117116_bb1045","doi-asserted-by":"crossref","first-page":"6117","DOI":"10.3390\/ijms25116117","article-title":"Extracellular vesicles in diabetic cardiomyopathy-state of the art and future perspectives","volume":"25","author":"Zygmunciak","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2026.117116_bb1050","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.2337\/dbi16-0041","article-title":"Exosomes in diabetic cardiomyopathy: the next-generation therapeutic targets?","volume":"65","author":"Sahoo","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2026.117116_bb1055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1348043","article-title":"MSC exosomes attenuate sterile inflammation and necroptosis associated with TAK1-pJNK-NFKB mediated cardiomyopathy in diabetic ApoE KO mice","volume":"15","author":"Banerjee","year":"2024","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2026.117116_bb1060","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/CIRCRESAHA.117.310712","article-title":"Safety and efficacy of the intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure","volume":"121","author":"Bartolucci","year":"2017","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.intimp.2026.117116_bb1065","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jacc.2016.11.009","article-title":"Randomized comparison of allogeneic vs. autologous mesenchymal stem cells for non-ischemic dilated cardiomyopathy: POSEIDON-DCM trial","volume":"69","author":"Hare","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.intimp.2026.117116_bb1070","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.707336","article-title":"Novel insights into the pathogenesis of diabetic cardiomyopathy and pharmacological strategies","volume":"8","author":"Mu\u00f1oz-C\u00f3rdova","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"17","key":"10.1016\/j.intimp.2026.117116_bb1075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25179481","article-title":"Diabetic cardiomyopathy: role of cell death, exosomes, fibrosis and epicardial adipose tissue","volume":"25","author":"Galeone","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2026.117116_bb1080","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.2337\/db15-1563","article-title":"Hsp20-mediated activation of exosome biogenesis in cardiomyocytes improves cardiac function and angiogenesis in diabetic mice","volume":"65","author":"Wang","year":"2016","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.intimp.2026.117116_bb1085","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1111\/jcmm.12607","article-title":"Endothelial microparticles reduce ICAM-1 expression in a microRNA-222-dependent mechanism","volume":"19","author":"Jansen","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.intimp.2026.117116_bb1090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2018.04.006","article-title":"Self-assembled hyaluronic acid nanoparticles: implications as a nanomedicine for treatment of type 2 diabetes","volume":"279","author":"Rho","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.intimp.2026.117116_bb1095","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.actbio.2021.06.015","article-title":"Ultrasound-assisted C3F8-filled PLGA nanobubbles for enhanced FGF21 delivery and improved prophylactic treatment of diabetic cardiomyopathy","volume":"130","author":"Gao","year":"2021","journal-title":"Acta Biomater."},{"issue":"1","key":"10.1016\/j.intimp.2026.117116_bb1100","doi-asserted-by":"crossref","first-page":"13786","DOI":"10.1038\/s41598-020-69745-x","article-title":"Systemically-delivered biodegradable PLGA alters gut microbiota and induces transcriptomic reprogramming in the liver in an obesity mouse model","volume":"10","author":"Chaplin","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2026.117116_bb1105","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3389\/fbioe.2019.00261","article-title":"Hazard assessment of polymeric Nanobiomaterials for drug delivery: what can we learn from literature so far","volume":"7","author":"Jesus","year":"2019","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.intimp.2026.117116_bb1110","article-title":"Antigen-specific T cell immunotherapy by in vivo mRNA delivery","author":"Su","year":"2024","journal-title":"bioRxiv"},{"issue":"5","key":"10.1016\/j.intimp.2026.117116_bb1115","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1021\/acs.nanolett.6b04130","article-title":"Extra-large pore mesoporous silica nanoparticles for directing in vivo M2 macrophage polarization by delivering IL-4","volume":"17","author":"Kwon","year":"2017","journal-title":"Nano Lett."},{"issue":"12","key":"10.1016\/j.intimp.2026.117116_bb1120","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1080\/17435889.2025.2506351","article-title":"Salvia miltiorrhiza-derived exosome-like nanoparticles improve diabetic cardiomyopathy by inhibiting NLRP3 inflammasome-mediated macrophage pyroptosis via targeting the NEDD4\/SGK1 axis","volume":"20","author":"Peng","year":"2025","journal-title":"Nanomedicine (London)"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926009628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:49:33Z","timestamp":1786322973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926009628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":224,"alternative-id":["S1567576926009628"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117116","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetic cardiomyopathy: Target immune cell from mechanism to treatment","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.117116","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117116"}}